Zwitterionic poly(
sulfobetaine acrylamide) (pSBAA)-based
nanocomposite hydrogels impregnated with germicidal
silver nanoparticles (AgNPs) were synthesized and implemented for the treatment of infected chronic
wounds. The zwitterionic
hydrogels exhibited excellent non-sticky properties and had reinforced mechanical properties by the addition of
hectorite nanoclay and
poly(ethylene glycol)dimethacrylate as physical and chemical crosslinkers, respectively. In addition, AgNPs were grown within the intercalated
clay/
polymer structure by in situ
free radical reduction, as confirmed by UV-vis spectroscopy and transmission electron microscopy (TEM). The
silver-containing pSBAA
nanocomposite hydrogels (pSBAA/Ag) exhibited germicidal properties against Gram-positive S. epidermidis and Gram-negative P. aeruginosa. The zwitterionic
hydrogels show higher water content than
2-hydroxyethyl methacrylate (
pHEMA)
hydrogels, owing to the strong hydration via ionic solvation. The negligible cytotoxicity of pSBAA/Ag
hydrogels was assessed with human fibroblasts by the MTT assay. Moreover, the zwitterionic
hydrogels demonstrated excellent resistance to the adsorption of
bovine serum albumin (BSA). To evaluate the feasibility of the
hydrogels for clinical application as
wound dressings, we created infected diabetic rat models and compared with commercial
wound dressings. The results show that pSBAA/Ag
hydrogels did not adhere to the newly formed tissue, and were readily removed from the
wounds after treatment for 3 days. Moreover, the healing recovery was evaluated by visual observation of infected dorsal
wounds on rats with induction of diabetes by
streptozotocin. The finding indicates complete healing with the pSBAA/Ag
hydrogels after 15 days, faster than other dressings. A histological examination also proved that the zwitterionic
hydrogels facilitated epithelialization and
collagen distribution in the infected diabetic
wounds. Consequently, these novel non-sticky and antimicrobial zwitterionic
nanocomposite hydrogels can have high potential for the treatment of infected chronic
wounds.